title: Are cardiac events during exercise therapy for heart failure predictable from the baseline variables?
abstract: BACKGROUND
  Exercise training (ET) is an emerging therapy for chronic heart failure, but the baseline patient characteristics for predicting cardiac events (CEs) during the course of ET remain unknown.
  
  
  RESULTS
  Of the 111 stable heart failure patients who participated in a 3-month ET program, 6 withdrew from the program for cardiac reasons and 9 had transient interruptions in the program because of CEs. The baseline clinical characteristics of these 15 patients (CE group) and the remaining 96 patients (No-CE group) were compared. Compared with the No-CE group, the CE group had a significantly higher prevalence of pacemaker/implantable cardioverter-defibrillators, larger left ventricular end-diastolic diameter (LVEDDs), lower peak oxygen uptake, greater ventilation drive, and higher plasma brain natriuretic peptide concentration at baseline. Multivariate logistic regression analysis showed that a larger LVEDD was a significant predictor of the occurrence of a transient interruption to or permanent withdrawal from the ET program because of CEs. Receiver operating characteristic curve analysis demonstrated that an LVEDD > or = 65 mm had a sensitivity of 93% and specificity of 48% in predicting CEs.
  
  
  CONCLUSIONS
  Patients with a large LVEDD (> or = 65 mm) at baseline should be monitored carefully during the course of an ET program.
authors.affiliation: Division of Cardiology, National Cardiovascular Center, Suita, Japan.
authors.forename: Isao
authors.initials: I
authors.lastname: Nishi
authors.forename: Teruo
authors.initials: T
authors.lastname: Noguchi
authors.forename: Shinichi
authors.initials: S
authors.lastname: Furuichi
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Iwanaga
authors.forename: Jiyoong
authors.initials: J
authors.lastname: Kim
authors.forename: Hideo
authors.initials: H
authors.lastname: Ohya
authors.forename: Naohiko
authors.initials: N
authors.lastname: Aihara
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Takaki
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Goto
mesh_terms: D000328:Adult; D002303:Cardiac Output, Low / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy*; D016022:Case-Control Studies; D017147:Defibrillators, Implantable; D003971:Diastole; D005081:Exercise Therapy / Q000009:adverse effects* / Q000379:methods; D017079:Exercise Tolerance / Q000502:physiology; D005260:Female; D006331:Heart Diseases / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology*; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D020097:Natriuretic Peptide, Brain / Q000097:blood; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity
chemical_list: D020097:Natriuretic Peptide, Brain